Connection
Wells Messersmith to Analysis of Variance
This is a "connection" page, showing publications Wells Messersmith has written about Analysis of Variance.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.046 |
|
|
|
-
Messersmith WA, Laheru DA, Senzer NN, Donehower RC, Grouleff P, Rogers T, Kelley SK, Ramies DA, Lum BL, Hidalgo M. Phase I trial of irinotecan, infusional 5-fluorouracil, and leucovorin (FOLFIRI) with erlotinib (OSI-774): early termination due to increased toxicities. Clin Cancer Res. 2004 Oct 01; 10(19):6522-7.
Score: 0.046